Careers  |  Media  |  Contact us

OncoLife – Hotspot 50 gene panel

Test Name

OncoLife – Hotspot 50 gene panel

Home Collection, Lab Visit

Test Code

ONCO0094

Test Components/ Genes/ Parameters

SNV/Indels: ABL1,AKT1,ALK, APC, ATM,BRAF,CDH1,CDKN2A, CSF1R,CTNNB1,EGFR,ERBB2,ERBB4,EZH2,FBXW7,FGFR1,FGFR2,FGFR3,FLT3,GNA11,GNAQ,GNAS,HNF1A,HRAS,IDH1,IDH2,JAK2,JAK3,KDR,KIT,KRAS, MET,MLH1,MPL,NOTCH1,NPM1,NRAS,PDGFRA,PIK3CA,PTEN,PTPN11,RB1,RET,SMAD4,SMARCB1, SMO, SRC, STK11, TP53,VHL

Sample Report

Click on Icon

Test Information

TAT DETAILS

15 days

PRE-TEST INSTRUCTIONS

NA

CLINICAL UTILITY

• The test provides comprehensive information of the actionable mutations at the start of therapy. • Helps in decision making for alternate and emerging targeted therapies for patients that are not responding to 1st & 2nd line therapies.

SPECIMEN STABILITY

Transport at ambient (18-25°C) temperature

METHODOLOGY

NGS

STORAGE TEMPERATURE

NA

SPECIMEN TYPE

Surgical tissue/Tissue Block

Frequently Asked Questions

OncoLife – Hotspot 50 gene panel
• The test provides comprehensive information of the actionable mutations at the start of therapy. • Helps in decision making for alternate and emerging targeted therapies for patients that are not responding to 1st & 2nd line therapies.
The patient should carry the FFPE tissue or block. This process is carried out by Surgical Onco in the hospital
The test is considered to identify the FDA approved targeted therapies for the patient as per the positive mutation
The test is performed by NGS technique
There is no risk associated with the test
NA